Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Micksche

Showing results (51-60 of 152) with videos related to

Pageof 16
Sort By:
Oncology|January 1, 1977
Active specific and active non-specific immunotherapy in patients with malignant melanomaE M Kokoschka, C Cerni, M Micksche
Die Pharmazie|May 1, 1992
In vitro interaction of interferon-alpha-2b with microspheres particlesM J Czejka, J Schüller, M Micksche
Oncology|January 1, 1978
Investigations on general immune reactivity in untreated cervical cancer patientsM Micksche, T Luger, W Michalica, et al.
Cellular Immunology|January 1, 1981
Natural killer cell activity in mouse aggregation chimerasL Elbling, S Yamagata, M Micksche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Randomised study using IFN-alpha versus IFN-alpha plus coumarin and cimetidine for treatment of advanced renal cell cancerP Sagaster, M Micksche, J Flamm, et al.
The International Journal of Biochemistry & Cell Biology|April 4, 2003
Effect of granulocyte-macrophage colony-stimulating factor on natural-killer cell mediated cytotoxicityB Kubista, K Trieb, I Herbacek, et al.
Oncology|January 1, 1979
Cell-mediated immunity in patients with cervical cancerC Cerni, G Tatra, R Berger, et al.
Onkologie|April 1, 1982
[Ifosfamide versus ifosfamide + CCNU in the treatment of inoperable small cell carcinoma of the lung. A clinical study]O Kokron, M Micksche, R Titscher, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Autologous tumor killing and natural cytotoxic activity of tumor-associated macrophages in cancer patientsE Yanagawa, A Uchida, M Moore, et al.
International Journal of Cancer|October 23, 1997
Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cellsW Berger, L Elbling, E Hauptmann, et al.
Pageof 16

Showing results (51-60 of 152) with videos related to

Sort By:
Pageof 16
Oncology|January 1, 1977
Active specific and active non-specific immunotherapy in patients with malignant melanomaE M Kokoschka, C Cerni, M Micksche
Die Pharmazie|May 1, 1992
In vitro interaction of interferon-alpha-2b with microspheres particlesM J Czejka, J Schüller, M Micksche
Oncology|January 1, 1978
Investigations on general immune reactivity in untreated cervical cancer patientsM Micksche, T Luger, W Michalica, et al.
Cellular Immunology|January 1, 1981
Natural killer cell activity in mouse aggregation chimerasL Elbling, S Yamagata, M Micksche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Randomised study using IFN-alpha versus IFN-alpha plus coumarin and cimetidine for treatment of advanced renal cell cancerP Sagaster, M Micksche, J Flamm, et al.
The International Journal of Biochemistry & Cell Biology|April 4, 2003
Effect of granulocyte-macrophage colony-stimulating factor on natural-killer cell mediated cytotoxicityB Kubista, K Trieb, I Herbacek, et al.
Oncology|January 1, 1979
Cell-mediated immunity in patients with cervical cancerC Cerni, G Tatra, R Berger, et al.
Onkologie|April 1, 1982
[Ifosfamide versus ifosfamide + CCNU in the treatment of inoperable small cell carcinoma of the lung. A clinical study]O Kokron, M Micksche, R Titscher, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Autologous tumor killing and natural cytotoxic activity of tumor-associated macrophages in cancer patientsE Yanagawa, A Uchida, M Moore, et al.
International Journal of Cancer|October 23, 1997
Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cellsW Berger, L Elbling, E Hauptmann, et al.
Pageof 16